Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

    • Volt Pharma Associates

    VPA supports life sciences companies, investors and academic institutes in developing new products, technologies and innovative approaches. VPA’s aim is to solve our clients’ product research, development and commercialisation challenges so they can achieve their business goals.

    This is a FREE LISTING on PMHUB

    Below are full profiles from other companies in related areas

    Genesis Research Group logo

    Genesis Research Group

    Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

    View Profile

    Market access, Regulatory affairs, Research and development

    Company Details

    Volt Pharma Associates
    Engesserstrasse 4B, Freiburg, 79114, Germany
    +49 172 6340202
    Contact Volt Pharma Associates
    Website

     Latest Content from PMHub 

    Create Long-lasting KOL Relationships, benefits of virtual advisory boards

    Videos and Podcasts | October 26, 2023 | Impetus Digital

    Here's another top reason why virtual advisory boards are simply better than in-person and hybrid advisory boards. #4. More Frequent Interactions and Long-lasting KOL Relationships Another important benefit of online...

    ISPOR 2023: Developing Fit-for-Purpose External Control Arms to Optimize Submissions to Regulatory and Health Technology Assessment Agencies

    Videos and Podcasts | October 23, 2023 | Genesis Research Group

    RPR: an agile, on-demand platform that provides clients with faster, higher-quality insights via direct, automated stakeholder engagement.

    Videos and Podcasts | October 23, 2023 | Genesis Research Group

    Accelerating Generation of Payer Insights & Evidence Across the Lifecycle to Achieve Optimal Access

    Videos and Podcasts | October 23, 2023 | Genesis Research Group

    ISPOR Europe: Generating Payer Insights & Evidence: Meeting the Challenges of New Evidence Paradigm

    Videos and Podcasts | October 23, 2023 | Genesis Research Group

    Accelerating Generation of Payer Insights & Evidence Across the Lifecycle to Achieve Optimal Access

    Videos and Podcasts | October 23, 2023 | Genesis Research Group

    Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

    Press Releases | October 23, 2023 | OPEN Health

    Dom Marchant, Chief Creative Officer, joins the executive leadership team at OPEN Health with a new vision to drive the creative communications practice

    Infographic: Rare Diseases in China

    White Papers and Resources | October 23, 2023 | Inizio

    How rare are rare diseases in China? Download this infographic to find out more and how we can offer guidance for pharma companies to consider.

    FREE Live Webinar – Solving your patient recruitment & retention challenges – 15th November 2023

    Press Releases | October 23, 2023 | Innovative Trials

    Join Innovative Trials and Avillion in this FREE webinar

    A New Era in Patient Recruitment & Retention

    Press Releases | October 23, 2023 | Innovative Trials

    Innovative Trials launches ‘first of its kind’ service to boost clinical trial patient recruitment and retention .